Masking of Obstructive Sleep Apnoea by Drug Induced Central Sleep Apnoea
Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2019, 87(3), 189-193; https://doi.org/10.5603/ARM.2019.0030
Submission received: 13 December 2018
/
Revised: 17 April 2019
/
Accepted: 17 April 2019
/
Published: 28 June 2019
Abstract
Benzodiazepines are widely prescribed hypnotic agents which have multiple proven neurological and respiratory side effects. However, literature is sparse with regards to the incidence and occurrence of new onset central sleep apnoea in individuals being treated with benzodiazepines for insomnia. We present a Case Report of a patient presenting with new onset central sleep apnoea secondary to long term usage of benzodiazepines, with resultant masking of his pre-existing obstructive sleep apnoea.
Share and Cite
MDPI and ACS Style
Chakrabarti, S.; Darisetty, S.; Gupta, N.; Ish, P. Masking of Obstructive Sleep Apnoea by Drug Induced Central Sleep Apnoea. Adv. Respir. Med. 2019, 87, 189-193. https://doi.org/10.5603/ARM.2019.0030
AMA Style
Chakrabarti S, Darisetty S, Gupta N, Ish P. Masking of Obstructive Sleep Apnoea by Drug Induced Central Sleep Apnoea. Advances in Respiratory Medicine. 2019; 87(3):189-193. https://doi.org/10.5603/ARM.2019.0030
Chicago/Turabian StyleChakrabarti, Shibdas, Srikar Darisetty, Nitesh Gupta, and Pranav Ish. 2019. "Masking of Obstructive Sleep Apnoea by Drug Induced Central Sleep Apnoea" Advances in Respiratory Medicine 87, no. 3: 189-193. https://doi.org/10.5603/ARM.2019.0030
